Back

Find the FamiCord brand in your country

Free guide

Smart Cells free guide

Download

Transplant stories

Real Treatments. Real Families. Real Hope.

Smart Cells was the first private UK stem cell bank to release samples for transplant — proving that family cord blood banking is not just about storage, but about delivering real therapies when they are needed most.

Why Stem Cell Transplants Matter

At some point in life, your child or family member may need access to stem cell therapy. Today, these treatments are being used for:

  • Blood cancers such as leukaemia and lymphoma
  • Inherited genetic disorders including thalassemia and sickle cell disease
  • Neurological conditions such as cerebral palsy and brain injury
  • Immune deficiencies and metabolic disorders
  • Emerging therapies for sports injuries, inflammatory conditions, and skin repair

By preserving your baby’s umbilical cord blood and tissue, you safeguard access to these life-saving and life-enhancing possibilities.

Proven Track Record

Smart Cells has released more stem cell samples for treatment than any other private UK bank, with a 100% success rate for every sample delivered to clinicians worldwide.

These samples have helped children and families across the globe face illnesses such as:

  • Cerebral Palsy
  • Thalassemia
  • Leukaemia
  • HSV Encephalitis
  • Immune system disorders

Each transplant is more than a statistic — it represents a child given new options, and a family given hope.

A Milestone for Families and for Science

Every successful release shows how far the field of stem cell research has advanced. What was once only a possibility is now a proven therapy.

Yet many parents are still unaware of the benefits of storing their baby’s cord blood and tissue. Smart Cells is working to change that — by raising awareness, sharing real transplant stories, and supporting research into the next generation of regenerative treatments.

Powered by FamiCord: Europe’s Stem Cell Leader in banking and use of cells

As part of the FamiCord Group, Europe’s largest family stem cell bank and one of the world’s top three:

  • Families gain access to 1,000,000+ stored cord blood units across the network
  • Therapies are supported by specialist research centres and clinical teams in 35+ countries including FamiCord Programme for brain disorders
  • FamiCordTx, the group’s advanced therapies division, is actively developing new cell-based treatments to extend the possibilities for families everywhere

Together, Smart Cells and FamiCord stand at the forefront of innovation, offering parents confidence today — and hope for tomorrow.

FamiCord Group releases

Patients

7800+

Expand table
No. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
1501 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 69
1502 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 70
1503 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 75
1504 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 56
1505 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 23
1506 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 54
1507 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 69
1508 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 70
1509 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 65
1510 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 48
1511 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2024 Standard Therapy Germany 72
1512 Bone Marrow Family Allogeneic Chronic Lymphocytic Leukemia Richter Transformation Hematology 2024 Standard Therapy Poland 55
1513 Bone Marrow Family Allogeneic Chronic Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 63
1514 Bone Marrow Family Allogeneic Follicular Lymphoma Hematology 2024 Standard Therapy Poland 48
1515 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 65
1516 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Germany 58
1517 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 70
1518 Bone Marrow Family Allogeneic Myelodysplastic Syndrome – Refractory Cytopenia Of Childhood Hematology 2024 Standard Therapy Poland 14
1519 Bone Marrow Family Allogeneic Myelodysplastic Syndrome/ Myeloproliferative Neoplasms Hematology 2024 Standard Therapy Germany 61
1520 Bone Marrow Family Allogeneic Myelodysplastic Syndrome-MPN Hematology 2024 Standard Therapy Poland 71
1521 Bone Marrow Family Allogeneic Myelofibrosis Hematology 2024 Standard Therapy Poland 68
1522 Bone Marrow Family Allogeneic Non-Hodgkin Lymphoma Hematology 2024 Standard Therapy Poland 64
1523 Bone Marrow Family Allogeneic Polycythemia Vera/Myelofibrosis Hematology 2024 Standard Therapy Poland 74
1524 Bone Marrow Family Allogeneic Primary Myelofibrosis Hematology 2024 Standard Therapy Germany 62
1525 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 68
1526 Bone Marrow Family Allogeneic Myelodysplasia Hematology 2024 Standard Therapy United Kingdom 57
1527 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Germany 69
1528 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 58
1529 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 60
1530 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 71
1531 Bone Marrow Family Allogeneic High risk Myelodysplastic Syndrome Hematology 2024 Standard Therapy Germany 69
1532 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 74
1533 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 15
1534 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 8
1535 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 12
1536 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 8
1537 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 52
1538 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 57
1539 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 66
1540 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 5
1541 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 54
1542 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 56
1543 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 3
1544 Bone Marrow Allogeneic Adrenoleukodystrophy Hematology 2024 Standard Therapy Poland 7
1545 Bone Marrow Allogeneic Adrenoleukodystrophy Hematology 2024 Standard Therapy Poland 7
1546 Bone Marrow Allogeneic Adrenoleukodystrophy Hematology 2024 Standard Therapy Poland 9
1547 Bone Marrow Allogeneic B-Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 7
1548 Bone Marrow Allogeneic Chronic Granulomatous Disease Hematology 2024 Standard Therapy Poland 4
1549 Bone Marrow Allogeneic Chronic Granulomatous Disease Hematology 2024 Standard Therapy Poland 41
1550 Bone Marrow Allogeneic Chronic Lymphocytic Leukemia Richter Transformation Hematology 2024 Standard Therapy Poland 55
1551 Bone Marrow Allogeneic Chronic Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 67
1552 Bone Marrow Allogeneic Chronic Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 12
1553 Bone Marrow Allogeneic Diffuse Large B-Cell Lymphoma Hematology 2024 Standard Therapy Poland 61
1554 Bone Marrow Allogeneic Genetically Determined Thrombocytopenia Hematology 2024 Standard Therapy Poland 4
1555 Bone Marrow Allogeneic High Risk Acute Myeloid Leukaemia Hematology 2024 Standard Therapy Poland 13
1556 Bone Marrow Allogeneic Hodgkin Lymphoma Hematology 2024 Standard Therapy Poland 32
1557 Bone Marrow Allogeneic Inherited Metabolic Disease Hematology 2024 Standard Therapy Poland 11
1558 Bone Marrow Allogeneic Mds-Rcc Relapse Hematology 2024 Standard Therapy Poland 14
1559 Bone Marrow Allogeneic Mixed Cellularity Hodgkin Lymphoma Hematology 2024 Standard Therapy Poland 43
1560 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 14
1561 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 8
1562 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 14
1563 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 67
1564 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 9
1565 Bone Marrow Allogeneic Osteopetrosis type B Hematology 2024 Standard Therapy Poland 13
1566 Bone Marrow Allogeneic Other Leukemia Hematology 2024 Standard Therapy Poland 9
1567 Bone Marrow Allogeneic Primary Immunodeficiency Hematology 2024 Standard Therapy Poland 7
1568 Bone Marrow Allogeneic Primary Immunodeficiency Xlp-1 Hematology 2024 Standard Therapy Poland 18
1569 Bone Marrow Allogeneic Relapse T-Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 12
1570 Bone Marrow Allogeneic Secondary Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 4
1571 Bone Marrow Allogeneic Secondary Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 15
1572 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 7
1573 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 3
1574 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 10
1575 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 21
1576 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 18
1577 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 49
1578 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 16
1579 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 24
1580 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 13
1581 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 14
1582 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 21
1583 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 7
1584 Bone Marrow Allogeneic Severe Combined Immunodeficiency Hematology 2024 Standard Therapy Poland 2
1585 Bone Marrow Allogeneic Severe Congenital Neutropenia Hematology 2024 Standard Therapy Poland 1
1586 Bone Marrow Allogeneic Shwachman-Diamond Syndrome Hematology 2024 Standard Therapy Poland 10
1587 Bone Marrow Allogeneic Sickle Cell Disease Hematology 2024 Standard Therapy Poland 9
1588 Bone Marrow Allogeneic Biphenotypic Acute Leukemia Hematology 2024 Standard Therapy Ukraine 10
1589 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 58
1590 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy United Kingdom 12
1591 Bone Marrow Allogeneic hemophagocytic lymphohistiocytosis Hematology 2024 Standard Therapy Sweden 4 months
1592 Bone Marrow Allogeneic Severe combined immunodeficiency Hematology 2024 Standard Therapy Germany 1
1593 Bone Marrow Allogeneic Beta-Thalassemia Major Hematology 2024 Standard Therapy India 11
1594 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Austria 4
1595 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Norway 33
1596 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Spain 16
1597 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Switzerland 5
1598 Bone Marrow Allogeneic T- Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Ireland 6
1599 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 12
1600 Bone Marrow Allogeneic Severe Combined Immunodeficiency Hematology 2024 Standard Therapy USA 4 months
Expand table

Stem cell transplantation has become an established procedure

700,000

cord blood collections have been undertaken globally

50,000

hematopoietic stem cell transplants take place every year

400/500

of these transplants are in Europe

Our transplant stories

Smart Cells have released 24 UK
samples to six countries.

Stem cells hold the key to more than 80 life-changing treatments, with clinical trials underway on many more. Replacing damaged cells and tissue, they can even save a child’s life.

Icon

100% infusion success rate

For samples released for transplant.

Icon

3 months – 12 yrs old

Stored cord blood samples have been successfully released for use in transplant for children aged as little as 3 months to 12 years old.

Icon

46% self | 54% siblings

Smart Cells have successfully released stored cord blood samples that have been used for treatment with the child it was collected from and also siblings.

Smart Cells releases

UK samples released

24

Expand table
Sample release date Medical condition Recipient relationship Age of the recipient Unit volume Medical center Country
2005.11 Thalassemia Allogeneic (Sibling) 4 Years 144ml Mount Vernon Hospital Singapore
2005.11 Leukaemia Allogeneic (Sibling) Restricted Restricted Stem Cells and Immunology Department, Birmingham UK
2007.02 Thalassemia Allogeneic (Sibling) 7 Years 76ml Kinderlink der Tu Munchen Germany
2009.08 Cerebral Palsy Autologous (Self) 3 Years 51ml Duke University, North Carolina USA
2010.01 Cerebral Palsy Autologous (Self) 3 Years 81ml Duke University, North Carolina USA
2013.10 Thalassemia Allogeneic (Sibling) 5 Years 58ml Catherine Lewis Centre, Hammersmith UK
2014.01 Leukaemia Allogeneic (Sibling) 4 Years 71ml Medizinische Hochschule, Hanover Germany
2014.05 Cerebral Palsy Autologous (Self) 1 year 68ml Duke University, North Carolina USA
2014.06 HSV Encephalitis & NMDA Receptor Antibody Virus Autologous (Self) 2 Years 57ml Duke University, North Carolina USA
2014.08 Hypoxic Ischemic Encephalopathy (HIE) Autologous (Self) 3 Months 39ml Duke University, North Carolina USA
2015.02 Hypoxic Ischemic Encephalopathy (HIE) Autologous (Self) 6 Months 53ml Duke University, North Carolina USA
2015.03 Severe Combined Immune Deficiency Autologous (Self) 3 Months 74ml Duke University, North Carolina USA
2015.03 Sickle Cell Disease Allogeneic (Sibling) 2 .5 Years 57ml BLK Hospital, New Delhi India
2015.11 Thalassemia Allogeneic (Sibling) 12 Years 87ml Children’s Hospital of Pittsburgh of UPMC USA
2016.03 Cerebral Palsy Allogeneic (Sibling) 6 Years 101ml Duke University, North Carolina USA
2017.04 Lymphoblastic Leukaemia (^1) N/A (Identical twin girls) Restricted 125ml Bambin Gesu Childrens’ Hospital, Rome Italy
2017.06 Cerebral Palsy Autologous (Self) 7 Years 82ml Duke University, North Carolina USA
2017.06 Cerebral Palsy Autologous (Self) 3.4 Years 132ml Duke University, North Carolina USA
2018.03 Autism Autologous (Self) 5.4 Years 73ml Duke University, North Carolina USA
2018.03 Cerebral Palsy Autologous (Self) 3.4 years 132ml Duke University, North Carolina USA
2019.06 Cerebral Palsy Allogeneic (Sibling) 3 Years 104ml Duke University, North Carolina USA
2022.02 Cerebral Palsy Allogeneic (Sibling) 11 Years 185ml Duke University, North Carolina USA
2023.08 Cerebral Palsy Allogeneic (Sibling) 3 Years 46ml Duke University, North Carolina USA
2024.01 Thalassaemia Allogeneic (Sibling) 8 Years 45ml Cincinnati Children’s Hospital Medical Center USA
Expand table
Icon

Ready to get started or need more information?